AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in the main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The company also is selectively active in the areas of Autoimmunity, Neuroscience and Infection. AstraZeneca operates in over 100 countries and millions of patients use its innovative medicines worldwide.
Russia is one of the key markets for AstraZeneca. The company employs over 1000 people in more than 70 cities across Russia. About 40 of AstraZeneca’s innovative medicines are licensed for use in Russia. In October 2015, the AstraZeneca pharmaceutical plant was officially opened in Kaluga region.
Limited Liability Company
3/1, Begovaya str., Moscow, 125284,
Tel. +7 495 799 5699
Fax +7 495 799 5698